Regulus Therapeutics | RGLS - Fremdkapital



Fremdkapital Veränderung Datum
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Alterity Therapeutics Limited AUD 43.68K 59.53K 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Biogen USD 6.29B 1.4M 2025-09
Cipla INR 2.98B 454.6M 2025-09
Clal Biotechnology ILS 25.96M 18.48M 2023-12
Compugen USD 0 0 2024-12
CSL USD 10.42B 273M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Grifols EUR 9.95B 722.93M 2025-12
Immunic USD 0 0 2024-06
Incyte USD 30.2M 5.17M 2025-12
Intrexon USD 0 198.67M 2024-06
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
Lexicon Pharmaceuticals USD 49.41M 7.1M 2025-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
Merck USD 39.97B 6B 2025-09
Omeros USD 403.72M 27.2M 2024-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 150.06M 2025-12
Takeda JPY 4.27T 81.29B 2025-12